Selected research
Industry Growth & Trends
Global Ketoprofen Gel Industry Growth and Trends Forecast to 2032
Market perspective
The global Ketoprofen Gel market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Ketoprofen Gel is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Ketoprofen Gel is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Ketoprofen Gel is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Ketoprofen Gel include Aventis Pharma, Hanmi Pharm. Co., Ltd., Mylan N.V., Pierre Fabre, Menarini, Sanofi and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Ketoprofen Gel market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Ketoprofen Gel market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Ketoprofen Gel market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Ketoprofen Gel.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Ketoprofen Gel market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Ketoprofen Gel Market by Company
Aventis Pharma
Hanmi Pharm. Co., Ltd.
Mylan N.V.
Pierre Fabre
Menarini
Sanofi
Teva Pharmaceutical Industries
Ketoprofen Gel Segment by Type
1g:0.025g
30g:0.9g
Ketoprofen Gel Segment by Application
Hospital
Clinic
Others
Ketoprofen Gel Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ketoprofen Gel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Ketoprofen Gel and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ketoprofen Gel.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ketoprofen Gel manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Ketoprofen Gel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1g:0.025g
- 30g:0.9g
Applications
- Hospital
- Clinic
- Others
Companies covered
- Aventis Pharma
- Hanmi Pharm. Co., Ltd.
- Mylan N.V.
- Pierre Fabre
- Menarini
- Sanofi
- Teva Pharmaceutical Industries
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Ketoprofen Gel Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Ketoprofen Gel Sales Estimates and Forecasts (2021-2032)
- 1.3 Ketoprofen Gel Market by Type
- 1.3.1 1g:0.025g
- 1.3.2 30g:0.9g
- 1.4 Global Ketoprofen Gel Market Size by Type
- 1.4.1 Global Ketoprofen Gel Market Size Overview by Type (2021-2032)
- 1.4.2 Global Ketoprofen Gel Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Ketoprofen Gel Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Ketoprofen Gel Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Ketoprofen Gel Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Ketoprofen Gel Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Ketoprofen Gel Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Ketoprofen Gel Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Ketoprofen Gel Industry Trends
- 2.2 Ketoprofen Gel Industry Drivers
- 2.3 Ketoprofen Gel Industry Opportunities and Challenges
- 2.4 Ketoprofen Gel Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Ketoprofen Gel Revenue (2021-2026)
- 3.2 Global Top Players by Ketoprofen Gel Sales (2021-2026)
- 3.3 Global Top Players by Ketoprofen Gel Price (2021-2026)
- 3.4 Global Ketoprofen Gel Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Ketoprofen Gel Major Company Production Sites & Headquarters
- 3.6 Global Ketoprofen Gel Company, Product Type & Application
- 3.7 Global Ketoprofen Gel Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Ketoprofen Gel Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Ketoprofen Gel Players Market Share by Revenue in 2025
- 3.8.3 2025 Ketoprofen Gel Tier 1, Tier 2, and Tier 3
4 Ketoprofen Gel Regional Status and Outlook
- 4.1 Global Ketoprofen Gel Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Ketoprofen Gel Historic Market Size by Region
- 4.2.1 Global Ketoprofen Gel Sales in Volume by Region (2021-2026)
- 4.2.2 Global Ketoprofen Gel Sales in Value by Region (2021-2026)
- 4.2.3 Global Ketoprofen Gel Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Ketoprofen Gel Forecasted Market Size by Region
- 4.3.1 Global Ketoprofen Gel Sales in Volume by Region (2027-2032)
- 4.3.2 Global Ketoprofen Gel Sales in Value by Region (2027-2032)
- 4.3.3 Global Ketoprofen Gel Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Ketoprofen Gel by Application
- 5.1 Ketoprofen Gel Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Ketoprofen Gel Market Size by Application
- 5.2.1 Global Ketoprofen Gel Market Size Overview by Application (2021-2032)
- 5.2.2 Global Ketoprofen Gel Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Ketoprofen Gel Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Ketoprofen Gel Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Ketoprofen Gel Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Ketoprofen Gel Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Ketoprofen Gel Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Ketoprofen Gel Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Aventis Pharma
- 6.1.1 Aventis Pharma Company Information
- 6.1.2 Aventis Pharma Business Overview
- 6.1.3 Aventis Pharma Ketoprofen Gel Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Aventis Pharma Ketoprofen Gel Product Portfolio
- 6.1.5 Aventis Pharma Recent Developments
- 6.2 Hanmi Pharm. Co., Ltd.
- 6.2.1 Hanmi Pharm. Co., Ltd. Company Information
- 6.2.2 Hanmi Pharm. Co., Ltd. Business Overview
- 6.2.3 Hanmi Pharm. Co., Ltd. Ketoprofen Gel Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Hanmi Pharm. Co., Ltd. Ketoprofen Gel Product Portfolio
- 6.2.5 Hanmi Pharm. Co., Ltd. Recent Developments
- 6.3 Mylan N.V.
- 6.3.1 Mylan N.V. Company Information
- 6.3.2 Mylan N.V. Business Overview
- 6.3.3 Mylan N.V. Ketoprofen Gel Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Mylan N.V. Ketoprofen Gel Product Portfolio
- 6.3.5 Mylan N.V. Recent Developments
- 6.4 Pierre Fabre
- 6.4.1 Pierre Fabre Company Information
- 6.4.2 Pierre Fabre Business Overview
- 6.4.3 Pierre Fabre Ketoprofen Gel Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Pierre Fabre Ketoprofen Gel Product Portfolio
- 6.4.5 Pierre Fabre Recent Developments
- 6.5 Menarini
- 6.5.1 Menarini Company Information
- 6.5.2 Menarini Business Overview
- 6.5.3 Menarini Ketoprofen Gel Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Menarini Ketoprofen Gel Product Portfolio
- 6.5.5 Menarini Recent Developments
- 6.6 Sanofi
- 6.6.1 Sanofi Company Information
- 6.6.2 Sanofi Business Overview
- 6.6.3 Sanofi Ketoprofen Gel Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sanofi Ketoprofen Gel Product Portfolio
- 6.6.5 Sanofi Recent Developments
- 6.7 Teva Pharmaceutical Industries
- 6.7.1 Teva Pharmaceutical Industries Company Information
- 6.7.2 Teva Pharmaceutical Industries Business Overview
- 6.7.3 Teva Pharmaceutical Industries Ketoprofen Gel Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Teva Pharmaceutical Industries Ketoprofen Gel Product Portfolio
- 6.7.5 Teva Pharmaceutical Industries Recent Developments
7 North America by Country
- 7.1 North America Ketoprofen Gel Sales by Country
- 7.1.1 North America Ketoprofen Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Ketoprofen Gel Sales by Country (2021-2026)
- 7.1.3 North America Ketoprofen Gel Sales Forecast by Country (2027-2032)
- 7.2 North America Ketoprofen Gel Market Size by Country
- 7.2.1 North America Ketoprofen Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Ketoprofen Gel Market Size by Country (2021-2026)
- 7.2.3 North America Ketoprofen Gel Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Ketoprofen Gel Sales by Country
- 8.1.1 Europe Ketoprofen Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Ketoprofen Gel Sales by Country (2021-2026)
- 8.1.3 Europe Ketoprofen Gel Sales Forecast by Country (2027-2032)
- 8.2 Europe Ketoprofen Gel Market Size by Country
- 8.2.1 Europe Ketoprofen Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Ketoprofen Gel Market Size by Country (2021-2026)
- 8.2.3 Europe Ketoprofen Gel Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Ketoprofen Gel Sales by Country
- 9.1.1 Asia-Pacific Ketoprofen Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Ketoprofen Gel Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Ketoprofen Gel Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Ketoprofen Gel Market Size by Country
- 9.2.1 Asia-Pacific Ketoprofen Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Ketoprofen Gel Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Ketoprofen Gel Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Ketoprofen Gel Sales by Country
- 10.1.1 South America Ketoprofen Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Ketoprofen Gel Sales by Country (2021-2026)
- 10.1.3 South America Ketoprofen Gel Sales Forecast by Country (2027-2032)
- 10.2 South America Ketoprofen Gel Market Size by Country
- 10.2.1 South America Ketoprofen Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Ketoprofen Gel Market Size by Country (2021-2026)
- 10.2.3 South America Ketoprofen Gel Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Ketoprofen Gel Sales by Country
- 11.1.1 Middle East and Africa Ketoprofen Gel Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Ketoprofen Gel Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Ketoprofen Gel Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Ketoprofen Gel Market Size by Country
- 11.2.1 Middle East and Africa Ketoprofen Gel Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Ketoprofen Gel Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Ketoprofen Gel Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Ketoprofen Gel Value Chain Analysis
- 12.1.1 Ketoprofen Gel Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Ketoprofen Gel Production Mode & Process
- 12.2 Ketoprofen Gel Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Ketoprofen Gel Distributors
- 12.2.3 Ketoprofen Gel Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst